Latest Stories
AMC Entertainment (AMC) Stock Trades Down, Here Is Why
Shares of theater company AMC Entertainment (NYSE:AMC) fell 8.1% in the morning session after the company announced it agreed to sell up to $150 million of its Class A common stock.
Why Is AppLovin (APP) Stock Soaring Today
Shares of mobile app technology company AppLovin (NASDAQ:APP) jumped 13.8% in the morning session after a wave of positive analyst commentary highlighted the company's business prospects and powerful advertising technology.
Why Hims & Hers Health (HIMS) Stock Is Nosediving
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 23.6% in the morning session after the company stopped offering its copycat version of Novo Nordisk's popular weight-loss drug, Wegovy, following intense regulatory pressure and legal action.
Merchants Bancorp (MBIN) Stock Trades Up, Here Is Why
Shares of diversified bank holding company Merchants Bancorp (NASDAQCM:MBIN) jumped 7.7% in the morning session after S&P Dow Jones Indices announced the company would be added to the S&P SmallCap 600 index.
monday.com (MNDY) Stock Trades Down, Here Is Why
Shares of work management platform monday.com (NASDAQ:MNDY) fell 21.4% in the morning session after the company reported fourth-quarter 2025 results that beat expectations but issued a weaker-than-expected financial outlook for 2026.
EHC Q4 Deep Dive: Labor Cost Control and Capacity Expansion Drive Outperformance
Health care services provider Encompass Health (NYSE:EHC) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 9.9% year on year to $1.54 billion. The company’s outlook for the full year was close to analysts’ estimates with revenue guided to $6.42 billion at the midpoint. Its non-GAAP profit of $1.46 per share was 12.1% above analysts’ consensus estimates.
monday.com’s (NASDAQ:MNDY) Q4 CY2025: Beats On Revenue But Stock Drops 13.3%
Work management platform monday.com (NASDAQ:MNDY) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with sales up 24.6% year on year to $333.9 million. On the other hand, next quarter’s revenue guidance of $339 million was less impressive, coming in 1.1% below analysts’ estimates. Its non-GAAP profit of $1.04 per share was 13.2% above analysts’ consensus estimates.
Kyndryl (NYSE:KD) Misses Q4 CY2025 Revenue Estimates, Stock Drops 25.3%
IT infrastructure services provider Kyndryl (NYSE:KD) fell short of the market’s revenue expectations in Q4 CY2025 as sales rose 3.1% year on year to $3.86 billion. Its non-GAAP profit of $0.52 per share was 13.7% below analysts’ consensus estimates.
Sally Beauty (NYSE:SBH) Posts Q4 CY2025 Sales In Line With Estimates
Beauty supply retailer Sally Beauty (NYSE:SBH) met Wall Street’s revenue expectations in Q4 CY2025, but sales were flat year on year at $943.2 million. The company expects next quarter’s revenue to be around $900 million, close to analysts’ estimates. Its non-GAAP profit of $0.48 per share was 3.4% above analysts’ consensus estimates.
Dynatrace’s (NYSE:DT) Q4 CY2025 Sales Top Estimates, Stock Jumps 10%
Cloud observability platform Dynatrace (NYSE:DT) reported Q4 CY2025 results topping the market’s revenue expectations, with sales up 18.2% year on year to $515.5 million. Guidance for next quarter’s revenue was better than expected at $520.5 million at the midpoint, 1.2% above analysts’ estimates. Its non-GAAP profit of $0.44 per share was 7.2% above analysts’ consensus estimates.